Objective: We assessed clinical effectiveness, longevity of treatment effects, and patient satisfaction with incobotulinumtoxinA for glabellar frown lines (GFL) treatment in Asian patients.
J Clin Aesthet Dermatol. 2019;12(10):39–44 by Rachel Lubart, Phd; Inbar Yariv MSc;
by Zoe Diana Draelos, MD Dr. Draelos is with Dermatology Consulting Services,
by Azahara Pérez Davó, PhD, MSc; Maria Teresa Truchuelo, MD, PhD; Maria
J Clin Aesthet Dermatol. 2019;12(5):E61–E68 by Deirdre Edge, PhD; Maiken Mellergaard, PhD;